Latest Health News
US CDC's Global Health Role in Jeopardy After Layoffs and Leadership Changes
The U.S. CDC's ability to conduct global health work is uncertain following chaotic layoffs, leadership upheaval under HHS Secretary Robert F. Kennedy Jr., and withdrawal from WHO. Staff question the agency's future amid misinformation and shuttered programs.
This comes as 2026 pressures intensify on global food systems with 318 million facing acute insecurity.
Indoor Air Pollution Poses Major Global Health Risk Across All Income Levels
A study across 150 countries shows indoor air pollution significantly contributes to premature deaths worldwide, with risks higher in nations like Benin due to energy deprivation. Access to clean fuels, reliable electricity, and higher healthcare spending reduce mortality risk from air pollution.
Indoor and outdoor pollution share structural roots, urging unified global action.
AI System Outperforms Humans in Analyzing Blood Cells for Diseases Like Leukemia
A generative AI analyzes blood cells with greater accuracy than experts, detecting subtle disease signs and recognizing its uncertainty. This advancement aids in spotting rare abnormalities missed by doctors.
Developed recently, it promises improved diagnostics.
Huntington’s Disease Breakthrough Paves Way for Genetic Disorder Advances in 2026
2025's success in slowing Huntington’s via repeat expansion disorder treatment drives 2026 research into complex cases like ALS using long-read sequencing. This milestone boosts investment in previously untreatable conditions.
Broader adoption of advanced tech is key for progress.
AI-Guided Target Identification to Transform Biologics Pipelines in 2026
In 2026, AI platforms will integrate multi-omic data for precise disease target ID before lab work, enhancing biologics discovery. This shift uncovers hidden mechanisms and supports clearer therapeutic paths.
Integration with LIMS accelerates workflows.
US and Malawi Sign $936 Million Health Pact Under America First Strategy
The US-Malawi agreement strengthens healthcare, combats infectious diseases, and promotes self-reliance. Part of an $11 billion effort replacing traditional aid models.
Multi-year MOUs planned with dozens of countries.
Vagus Nerve Stimulation Offers Lasting Relief for Treatment-Resistant Depression
A study shows enduring benefits from vagus nerve implants for severe depression patients. This builds on findings that the nerve protects heart cells from aging.
It highlights neural pathways in mental and cardiac health.
Almirall Advances Dermatology Pipeline with New Clinical Studies in 2026
Almirall plans PoC studies for anti-IL-21 mAb in hidradenitis suppurativa and others, plus Phase I for atopic dermatitis bispecific. Supported by growth in medical dermatology.
Targets multiple inflammatory skin diseases.
AbbVie Licenses Novel Bispecific Antibody for Advanced Solid Tumors
AbbVie partners with RemeGen on RC148, combining immune checkpoint and anti-angiogenic activity with ADCs for oncology. Aims to address patent cliffs via pipeline diversification.
Collaboration maximizes global potential.
UNC Breakthrough Reveals How Cells Respond to Common Prescription Drugs
UNC simulations show G protein dissociation in GPCRs, aiding safer drugs for heart disease and mental health without addiction risks. Matches lab results via accelerated molecular dynamics.
International collaboration validates findings.
Digital Twins Enter Mainstream in Clinical Development for 2026
Digital twins shift from pilots to routine use, optimizing trial protocols and reducing amendments. Regulatory clarity expected to boost adoption.
Enhances efficiency in drug development.
Lower-Dose Yellow Fever Vaccine Proves Non-Inferior in Infants
A trial with 420 infants showed 500 IU dose achieves seroconversion comparable to standard >13,000 IU. Conducted 2021-2023, supports safer vaccination strategies.
Published in The Lancet.